Canaccord Genuity Group Boosts Privia Health Group (NASDAQ:PRVA) Price Target to $30.00

Privia Health Group (NASDAQ:PRVA) had its price objective increased by analysts at Canaccord Genuity Group from $29.00 to $30.00 in a report issued on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price would indicate a potential upside of 19.02% from the stock’s current price.

Other equities research analysts have also recently issued research reports about the company. JPMorgan Chase & Co. boosted their target price on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Macquarie initiated coverage on Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective for the company. Stephens restated an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. Piper Sandler lifted their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday. Finally, Barclays boosted their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. One equities research analyst has rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $26.59.

Privia Health Group Trading Down 1.0 %

Shares of NASDAQ PRVA traded down $0.26 during mid-day trading on Friday, reaching $25.21. 263,685 shares of the company’s stock were exchanged, compared to its average volume of 639,648. Privia Health Group has a twelve month low of $15.92 and a twelve month high of $26.04. The firm has a market capitalization of $3.02 billion, a price-to-earnings ratio of 252.08, a PEG ratio of 3.47 and a beta of 0.87. The business has a fifty day simple moving average of $22.30 and a 200 day simple moving average of $20.55.

Institutional Investors Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently bought and sold shares of PRVA. First Horizon Advisors Inc. raised its stake in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after buying an additional 632 shares during the period. EverSource Wealth Advisors LLC lifted its stake in Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after acquiring an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. bought a new stake in shares of Privia Health Group in the 4th quarter worth $51,000. Quarry LP lifted its position in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after purchasing an additional 2,533 shares in the last quarter. Finally, KBC Group NV boosted its holdings in Privia Health Group by 34.6% during the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after purchasing an additional 871 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.